Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
IPO Year: 1995
Exchange: NASDAQ
Website: henryschein.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/22/2024 | $81.00 → $92.00 | Neutral → Outperform | Robert W. Baird |
| 2/26/2024 | $78.00 | Market Perform | Leerink Partners |
| 12/12/2023 | $71.00 → $82.00 | Neutral → Overweight | JP Morgan |
| 11/10/2023 | $70.00 | Hold → Buy | Stifel |
| 8/8/2022 | $80.00 | Sell → Neutral | UBS |
| 7/21/2022 | $93.00 → $85.00 | Buy → Neutral | Goldman |
| 6/14/2022 | $103.00 → $88.00 | Outperform → Neutral | Robert W. Baird |
| 5/13/2022 | $100.00 | Outperform | Credit Suisse |
| 2/16/2022 | $67.00 → $72.00 | Underweight | Morgan Stanley |
| 2/16/2022 | $90.00 → $100.00 | Outperform | Credit Suisse |
Third-quarter 2024 GAAP diluted EPS of $0.78 and non-GAAP diluted EPS of $1.22 Operating cash flow of $151 million for the third quarter of 2024; year-to-date operating cash flow of $644 million, up $112 million compared with year-to-date 2023 Increases 2024 full-year non-GAAP EPS guidance to $4.74 to $4.82 from $4.70 to $4.82 Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended September 28, 2024. "Our businesses performed well during the third quarter, driven by the continued successful implementation of our BOLD+1 Strategic Plan that is
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2024 financial results before the stock market opens on Tuesday, November 5, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be availabl
Highlights: Second-quarter 2024 GAAP diluted EPS of $0.80, and non-GAAP diluted EPS of $1.23 Operating cash flow of $296 million for the second quarter of 2024, year-to-date operating cash flow of $493 million up $192 million compared with year-to-date 2023 2024 full-year non-GAAP EPS guidance updated to $4.70 to $4.82 New restructuring plan targeting $75 million to $100 million in annual run-rate savings Share repurchase authorization increased by $500 million Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended June 29, 2024.
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its second quarter 2024 financial results before the stock market opens on Tuesday, August 6, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be availab
First-quarter 2024 sales growth of 3.7%, GAAP diluted EPS of $0.72 and non-GAAP diluted EPS of $1.10 Tightens total sales growth guidance range to 8% to 10%, reflecting continued recovery from last year's cyber incident and a strong pipeline of new specialty products and software innovation Affirms 2024 non-GAAP diluted EPS guidance of $5.00 to $5.16 and 2024 Adjusted EBITDA growth of more than 15% Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the first quarter ended March 30, 2024. "Our first-quarter financial results reflect solid earnings driven by
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2024 financial results before the stock market opens on Tuesday, May 7, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available o
Company Expands into High-Growth Extremities Market with Strategic Acquisition Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced it has completed the acquisition of TriMed, Inc., a global developer of solutions for the orthopedic treatment of lower extremities (foot and ankle) and upper extremities (primarily hand and wrist). Henry Schein announced the agreement to acquire a majority interest of TriMed on December 20, 2023. The addition of TriMed will strengthen Henry Schein's deep and longstanding relationship with existing Integrated Delivery Networks (IDNs) and Ambulatory Surgery C
Fourth quarter GAAP diluted EPS of $0.13. Solid fourth quarter financial results in line with the Company's guidance provided on November 13, 2023. Fourth quarter non-GAAP diluted EPS of $0.66, reflects: $0.05 of acquisition-related expenses and adjustments, and an estimated $0.70 to $0.75 from the cybersecurity incident. Introduces guidance for full-year 2024 non-GAAP diluted EPS of $5.00 to $5.16, reflecting growth of 11% to 15% compared with 2023, and full-year 2024 Adjusted EBITDA growth of more than 15%. Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financia
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its fourth quarter and full-year 2023 financial results before the stock market opens on Tuesday, February 27, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. The Company will also introduce its earnings expectations for the full-year 2024. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors
GAAP diluted EPS of $1.05 and non-GAAP diluted EPS of $1.32, reflecting stable net total sales growth of 3.1% 2023 non-GAAP diluted EPS guidance of $4.43 to $4.71 updated to reflect: a narrowing of previous guidance to $5.18 to $5.26 from $5.18 to $5.35 due to softening macroeconomic conditions, and an estimated $0.55 to $0.75 business interruption impact from the recent cybersecurity incident, which excludes any future insurance claim recovery Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended September 30, 2023. "We are report
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in December: Piper Sandler's Healthcare Conference at Lotte New York Palace Hotel, New York, on December 4, 2024, at 11:00 a.m. Eastern time. Evercore ISI HealthCONx Conference at Loews Coral Gables Hotel, Coral Gables, Florida, on December 5, 2024, at 9:10 a.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations. Abo
Acquisition will Enhance Home Delivery Options for Patients with Specialized Health Care Needs Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it has signed an agreement to acquire Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). The Acentus transaction follows Henry Schein's acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company's strategic commitment to the homecare medical supplies market. Henry Schein's homecare medical products platform will now have
Third-quarter 2024 GAAP diluted EPS of $0.78 and non-GAAP diluted EPS of $1.22 Operating cash flow of $151 million for the third quarter of 2024; year-to-date operating cash flow of $644 million, up $112 million compared with year-to-date 2023 Increases 2024 full-year non-GAAP EPS guidance to $4.74 to $4.82 from $4.70 to $4.82 Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended September 28, 2024. "Our businesses performed well during the third quarter, driven by the continued successful implementation of our BOLD+1 Strategic Plan that is
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in November: Stifel's Healthcare Conference at Lotte New York Palace Hotel, New York, on November 18, 2024, at 9:45 a.m. Eastern Standard Time. Jefferies London Healthcare Conference on November 19, 2024, at 1:30 p.m. Greenwich Mean Time/8:30 a.m. Eastern Standard Time. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations. About Henry S
GUELPH, ON / ACCESSWIRE / October 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on recent commercialization activities for its ZenGUARD™Antimicrobial Surgical Masks.As previously announced on July 24, 2024, the Company embarked on a Canada-wide sampling program for dental professionals facilitated by Henry Schein Inc. ("Henry Schein") that saw ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers across Canada. As a result of this program and the unique value proposition ZenGUARD™ Antimicrobial Surgical Masks bring to denta
Dental and Medical Professionals Who May Experience Operational, Logistical, or Financial Issues Are Encouraged to Call 800-999-9729 Henry Schein, Inc. (NASDAQ:HSIC) reminds its customers in Florida and all areas in the projected path of Hurricane Milton that the Henry Schein Customer Assistance Hotline is open for dental and medical professionals who may experience operational, logistical, or financial issues as a result of damage caused by the hurricane. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schein Members from 8 a.m. to 8 p.m. Eastern Time. "Team Schein remains at the ready to suppor
Program Demonstrates Company's Commitment to Corporate Citizenship Henry Schein, Inc. (NASDAQ:HSIC) today announced the annual launch of its 2024 Practice Pink® program, a global initiative that has donated more than $2 million over the past 18 years to help create awareness and support for the campaign against cancer. The program is an initiative of Henry Schein Cares, the Company's global corporate citizenship program. Through the Practice Pink program, Henry Schein, together with non-governmental organizations and supplier partners across North America and Europe, assists dental and medical health care professionals in raising awareness and support to help find a cure for cancer. By of
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2024 financial results before the stock market opens on Tuesday, November 5, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be availabl
Dentists and Physicians Who May Experience Operational, Logistical, or Financial Issues Are Encouraged to Call 800-999-9729 Henry Schein, Inc. (NASDAQ:HSIC) reminds its customers in Florida and all areas in the projected path of Hurricane Helene that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the hurricane. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schein Members from 8 a.m. to 8 p.m. Eastern Time. "As Hurricane Helene approaches Florida, Team Schein remains
Henry Schein Cares Foundation Partners With Five Global Relief Agencies, Provides Cash Grants and Pre-Positioned Health Care Product Donations for Quicker Response to Emergencies Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the launch of "Prepare to Care," an initiative of the Henry Schein Cares Foundation, Inc. (HSCF) to improve emergency preparedness and relief by pre-positioning health care supplies and cash donations with trusted relief agency partners. Through this initiative, Henry Schein and its Foundation will provide five non-governmental organization (NGO) relief agency p
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Goldman Sachs cut the price target for Lennar Corporation (NYSE:LEN) from $180 to $174. Goldman Sachs analyst Susan Maklari downgraded the stock from Buy to Neutral. Lennar shares gained 0.5% to close at $170.94 on Friday. See how other analysts view this stock. Piper Sandler increased the price target for NVIDIA Corporation (NASDAQ:NVDA) from $120 to $140. Piper Sandler analyst Harsh Kumar maintained an Overweight rating. NVIDIA shares fell 2.6% to close at $117.93 on Friday. See how other analyst
In the preceding three months, 6 analysts have released ratings for Henry Schein (NASDAQ:HSIC), presenting a wide array of perspectives from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 4 2 0 0 Last 30D 0 1 0 0 0 1M Ago 0 1 1 0 0 2M Ago 0 1 0 0 0 3M Ago 0 1 1 0 0 In the assessment of 12-month price targets, analysts unveil insights for Henry Schein, presenting an average target of $85.67, a high estimate of $92.00, and a low estimate of $72.00. Observing a
Baird analyst Jeff Johnson upgrades Henry Schein (NASDAQ:HSIC) from Neutral to Outperform and raises the price target from $81 to $92.
Evercore ISI Group analyst Ross Muken maintains Henry Schein (NASDAQ:HSIC) with a In-Line and lowers the price target from $75 to $72.
Ratings for Henry Schein (NASDAQ:HSIC) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 3 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 1 0 0 0 2M Ago 0 1 1 0 0 3M Ago 0 0 0 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $87.5, with a high estimate of $92.00 and a low estimate of $80.00. Holding firm without variation, the current averag
Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and maintains $92 price target.
Henry Schein's (NYSE:HSIC) short percent of float has risen 14.11% since its last report. The company recently reported that it has 6.06 million shares sold short, which is 5.42% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.45 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest
Tapered Pro Conical leverages the successful macro design of Tapered Pro with the proven and patented CONELOG® connection to provide clinicians with a predictable solution for immediate treatment, from single tooth to full arch. It is designed for surgical efficiency with a best-in-class conical connection.
Piper Sandler analyst Jason Bednar reiterates Henry Schein (NASDAQ:HSIC) with a Overweight and maintains $86 price target.
Henry Schein's (NYSE:HSIC) short percent of float has risen 5.32% since its last report. The company recently reported that it has 5.31 million shares sold short, which is 4.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.25 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest i
Joining Henry Schein's EMC are Steve Boggan and Bianka Wilson, Co-CEOs of the Global Oral Reconstruction Group, and Tom Popeck, CEO of the Healthcare Specialties Group Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, today announced that it has appointed three new members to the Company's Executive Management Committee (EMC) – Steve Boggan and Bianka Wilson, who were recently named Co-CEOs of the Company's Global Oral Reconstruction Group (GORG), and Tom Popeck, CEO of the Company's Healthcare Specialties Group (HSG). This press release features multimedia. View the full release here: https://www.busi
Applications for the Second Annual 2024 S.M.I.L.E. Healthcare Pathway Program are now being accepted Henry Schein, Inc. (NASDAQ:HSIC), National Dental Association (NDA), and Schattner Foundation are pleased to partner and present the S.M.I.L.E. (Student Mentoring with Immersive Learning and Enrichment) Healthcare Pathway Program. This innovative public-private partnership is designed to mentor and support aspiring healthcare professionals and enhance inclusivity within the dental field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220083937/en/ Applications are now being accepted for the 2024 program taking place July 7 t
WASHINGTON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The American Dental Association Foundation's Give Kids A Smile® (GKAS) program, one of the largest national initiatives focused on children and dental care, is kicking off at Howard University College of Dentistry on Thursday, Feb. 1 and Friday, Feb. 2, 2024. The American Dental Association (ADA) launched Give Kids A Smile 22 years ago as a way for dentists across the country to join with others in the community to provide free dental services to underserved children while also highlighting for policy makers the ongoing challenges that underserved families face in finding and affording dental care. The national Give Kids A Smile kick-of
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that its Board of Directors has appointed Carole T. Faig as an independent director to serve until the 2024 Annual Meeting of Stockholders in May, when she is expected to stand for re-election to the Board by a vote of the Company's stockholders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231218305776/en/Carole T. Faig (Photo: Business Wire) Ms. Faig brings to Henry Schein extensive expertise in finance, audit, and public accounting and particular experience in the health c
Clark Named to New Position as Chief Global Customer Experience Officer Benowitz Named to New Position as Chief Global Digital Transformation Officer Appointments Advance Implementation of 2022-2024 BOLD+1 Strategic Plan Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today the appointment of two executives – Trinh Clark and Leigh Benowitz – to the Company's Executive Management Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220801005699/en/Pictured left to right: Trinh Clark, Senior Vice President and Chief Globa
Nancy Lanni, Experienced Health Care Leader, Named Vice President and General Manager, Strategic Account Management Team Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today the appointment of Dirk Benson to the position of Vice President and Chief Commercial Officer of the Company's North America Distribution Group (NADG). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220516006085/en/Dirk Benson, Vice President and Chief Commercial Officer, North America Distribution Group, Henry Schein. (Photo: Business Wire) In this new posit
Gerald A. Benjamin will retire as Chief Administrative Officer Michael S. Ettinger will be promoted to Chief Operating Officer Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Gerald A. Benjamin plans to retire as Executive Vice President and Chief Administrative Officer, effective July 1, 2022, after 34 years with the Company. Mr. Benjamin, who will also retire from Henry Schein's Board of Directors at the end of his current term in May, will remain an adviser to the Company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/
CFO Steven Paladino will retire on April 29, 2022, to be succeeded by Ronald N. South, Henry Schein's Vice President, Corporate Finance and Chief Accounting Officer Mr. Paladino to remain a member of Henry Schein's Board of Directors and become an adviser to the Company following retirement Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Steven Paladino plans to retire as Executive Vice President and Chief Financial Officer, effective April 29, 2022, after 35 years with the Company. Ronald N. South, Henry Schein's Vice President, Corporate Finance since 2008 and Chief Accoun
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer. In this role, Graham will be responsible for driving Henry Schein's strategic communications with institutional investors and the securities analyst community as well as providing executive oversight from a financial perspective for several strategic initiatives. "Graham brings to this new role deep experience in finance management and leadership," said Steven Paladino, Executive Vice President and Chief Financial Officer.
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One, a joint venture of Henry Schein, Inc., and Internet Brands, has announced that Mike Baird will assume the role of Chief Executive Officer, leading all aspects of Henry Schein One’s business. In his new role of CEO, Mr. Baird will lead the organization in driving growth, developing more seamlessly integrated products, and advancing digital innovations that help customers build stronger practices and deliver quality care. “Taking on this role with Henry Schein One is an exciting opportunity to collaborate with an outstanding team,” Mr. Baird said. “We have tremendous potential to develop and execute forward-thinking strategies
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4/A - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
3 - HENRY SCHEIN INC (0001000228) (Issuer)
10-Q - HENRY SCHEIN INC (0001000228) (Filer)
8-K - HENRY SCHEIN INC (0001000228) (Filer)
10-Q - HENRY SCHEIN INC (0001000228) (Filer)
8-K - HENRY SCHEIN INC (0001000228) (Filer)
11-K - HENRY SCHEIN INC (0001000228) (Filer)
SD - HENRY SCHEIN INC (0001000228) (Filer)
8-K - HENRY SCHEIN INC (0001000228) (Filer)
10-Q - HENRY SCHEIN INC (0001000228) (Filer)
8-K - HENRY SCHEIN INC (0001000228) (Filer)
ARS - HENRY SCHEIN INC (0001000228) (Filer)
Robert W. Baird upgraded Henry Schein from Neutral to Outperform and set a new price target of $92.00 from $81.00 previously
Leerink Partners initiated coverage of Henry Schein with a rating of Market Perform and set a new price target of $78.00
JP Morgan upgraded Henry Schein from Neutral to Overweight and set a new price target of $82.00 from $71.00 previously
Stifel upgraded Henry Schein from Hold to Buy and set a new price target of $70.00
UBS upgraded Henry Schein from Sell to Neutral and set a new price target of $80.00
Goldman downgraded Henry Schein from Buy to Neutral and set a new price target of $85.00 from $93.00 previously
Robert W. Baird downgraded Henry Schein from Outperform to Neutral and set a new price target of $88.00 from $103.00 previously
Credit Suisse resumed coverage of Henry Schein with a rating of Outperform and set a new price target of $100.00
Morgan Stanley reiterated coverage of Henry Schein with a rating of Underweight and set a new price target of $72.00 from $67.00 previously
Credit Suisse reiterated coverage of Henry Schein with a rating of Outperform and set a new price target of $100.00 from $90.00 previously